检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:徐如敏 曹雨蝶 连晓芙 蔡烨 石世杰 张帅 张静 XU Rumin;CAO Yudie;LIAN Xiaofu;CAI Ye;SHI Shijie;ZHANG Shuai;ZHANG Jing(School of Life Sciences,Bengbu Medical University,Bengbu 233030,China)
机构地区:[1]蚌埠医科大学生命科学学院,安徽蚌埠233030
出 处:《海南医学院学报》2024年第22期1690-1696,共7页Journal of Hainan Medical University
基 金:安徽省教育厅自然科学研究重点项目(KJ2020A0578);安徽省大学生创新训练项目(S202210367073,S202310367096)。
摘 要:目的:探讨木犀草素对人卵巢癌A2780细胞的作用,并揭示其可能机制。方法:通过CCK-8检测木犀草素对A2780细胞活力的影响,确定加药浓度;克隆斑、划痕和Transwell实验检测木犀草素对A2780细胞增殖和转移能力的影响;并使用流式细胞术检测木犀草素作用下细胞凋亡水平的变化;凋亡、自噬及AKT-mTOR信号通路相关蛋白的表达情况则通过Western blot实验检测。结果:木犀草素抑制了A2780细胞活力、增殖和转移的能力;流式细胞术结果表明木犀草素呈浓度依赖性诱导A2780细胞凋亡;且自噬相关蛋白LC3-Ⅱ/LC3-Ⅰ比例增加,P62表达下降,P-AKT、P-mTOR与抗凋亡蛋白Bcl-2表达水平降低。结论:木犀草素通过AKT-mTOR信号通路诱导人卵巢癌A2780细胞凋亡和自噬,从而抑制卵巢癌细胞恶性进展。Objective:To investigate the effect of luteolin on human ovarian cancer A2780 cells and reveal its possible mechanism.Method:The effect of luteolin on the viability of A2780 cells was detected by CCK-8,and the concentration of luteolin was determined;the effects of luteolin on the proliferation and metastasis of A2780 cells were detected by clone spot,scratch,and Transwell assay;flow cytometry was used to detect the changes of apoptosis level under the action of luteolin;the expression of proteins related to apoptosis,autophagy,and AKT-mTOR signaling pathway was detected through Western blot experiments.Re⁃sults:Luteolin inhibited the viability,proliferation,and metastasis of A2780 cells;the proportion of autophagy related protein LC3-Ⅱ/LC3-Ⅰincreased,the expression of P62 decreased,and the expression levels of P-AKT,P-mTOR,and anti-apoptotic protein Bcl-2 decreased.Conclusion:Luteolin induces apoptosis and autophagy in human ovarian cancer A2780 cells through AKTmTOR signaling pathway,thereby inhibiting the malignant progression of ovarian cancer cells.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.7